000			01959 a2200529 4500
005			20250518063508.0
264		0	_c20210205
008			202102s 0 0 eng d
022			_a1724-6016
024	7		_a10.1177/1120672119878044 _2doi
040			_aNLM _beng _cNLM
100	1		_aTopouzis, Fotis
245	0	0	_aBrinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension. _h[electronic resource]
260			_bEuropean journal of ophthalmology _cJan 2021
300			_a103-111 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study; Randomized Controlled Trial
650	0	4	_aAdrenergic alpha-2 Receptor Agonists _xadverse effects
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntihypertensive Agents _xtherapeutic use
650	0	4	_aBrimonidine Tartrate _xadverse effects
650	0	4	_aCarbonic Anhydrase Inhibitors _xadverse effects
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Combinations
650	0	4	_aFemale
650	0	4	_aGlaucoma, Open-Angle _xdrug therapy
650	0	4	_aHumans
650	0	4	_aIntraocular Pressure _xdrug effects
650	0	4	_aLatanoprost _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOcular Hypertension _xdrug therapy
650	0	4	_aSulfonamides _xadverse effects
650	0	4	_aThiazines _xadverse effects
650	0	4	_aTonometry, Ocular
650	0	4	_aTravoprost _xtherapeutic use
700	1		_aGoldberg, Ivan
700	1		_aBell, Katharina
700	1		_aTatham, Andrew J
700	1		_aRidolfi, Antonia
700	1		_aHubatsch, Douglas
700	1		_aNicolela, Marcelo
700	1		_aDenis, Phillipe
700	1		_aLerner, S Fabian
773	0		_tEuropean journal of ophthalmology _gvol. 31 _gno. 1 _gp. 103-111
856	4	0	_uhttps://doi.org/10.1177/1120672119878044 _zAvailable from publisher's website
999			_c30185284 _d30185284